UK Marketing Company (Luton)
Innovation is something that we strive for across our business, not just in research and development. Our commitment to innovation in sales and marketing is a key to our success.
AstraZeneca’s UK Marketing Company (UKMC) is a part of our global commercial organisation, and is responsible for the marketing of our medicines in the UK.
Excellence in sales and marketing is core to our business, and we are focused on aligning with our customers in a changing and dynamic healthcare market and selling products that meet customers' needs, in a responsible and ethical way.
The healthcare industry is constantly changing, along with the NHS and our UK customers, and we are responding. We have restructured our UK sales and marketing business to align with the needs of healthcare professionals and the new NHS organisation.
In addition to trained sales representatives, we have introduced new ways of interacting with doctors, using online and telephone channels, and giving customers the opportunity to decide what kind of interaction they prefer.
Sales and marketing within a pharmaceutical environment requires the highest standards in order to meet regulations and codes of practice.
As a member of the Association of the British Pharmaceutical Industry (ABPI), all of our sales, marketing and communications activities are subject to the ABPI Code of Practice.
This code forms the basis for a stringent internal code applicable to all of our UK employees (as well as third parties acting on behalf of AstraZeneca) – the AstraZeneca UK Pharma Code.
In addition, a code of conduct for all AstraZeneca employees worldwide defines the integrity and high ethical standards as core values for AstraZeneca. It also provides guidance for the application of consistent standards of responsible behaviour across the company.
Our work at the UKMC, close to the centre of Luton, extends beyond the site to include community support and funding for local charities.
2558100 May 2013